<DOC>
	<DOCNO>NCT01580748</DOCNO>
	<brief_summary>There currently effective treatment bronchiectasis treat complication infection , bleeding , etc . Roflumilast newly develop anti-inflammatory drug proven effective stable COPD . We hypothesize Roflumilast might effective symptomatic bronchiectasis patient</brief_summary>
	<brief_title>Phase2 , Single Group , Open Clinical Trial Evaluate Efficacy Safety Roflumilast Symptomatic Bronchiectasis Patients</brief_title>
	<detailed_description />
	<mesh_term>Bronchiectasis</mesh_term>
	<criteria>Bronchiectasis CT chronic ( &gt; 3 month ) cough sputum need hospitalization life expectancy less six month pregnancy breast feed history acute respiratory infection within 4 week history take antibiotic within 4 week active hemoptysis % predict FEV &lt; 30 % severe liver disease ( Child Pugh Class B C )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>